Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Exercise/Conversion of 10,000 BCAX shares, $37.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 10,000 | $37.9K |
| Jul 14, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 10,000 | $37.9K |
| Jun 10, 2026 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 32,947 | n/a |
| May 20, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 15,000 | $56.8K |
| Apr 20, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 8,226 | $36.5K |
| Mar 20, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 6,499 | $24.6K |
| Mar 7, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 2,631 | $10.0K |
| Feb 4, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 450,000 | n/a |
| Dec 18, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 29,500 | $160.9K |
| Nov 25, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 41,163 | $156.0K |